Prostate-Specific Antigen (PSA) Test Market Size & Growth Insights: Emerging Trends and Future Projections 2025-2034

The Prostate Specific Antigen (PSA) Test Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Prostate Specific Antigen (PSA) Test Market Size and Projected Growth Rate?
The market size of the prostate specific antigen (PSA) test has experienced swift expansion in the past few years. The market will progress from a valuation of $4.15 billion in 2024 to around $4.66 billion in 2025, with a compound annual growth rate (CAGR) of 12.1%. Factors contributing to this growth during the historical period include enhanced awareness, an older population, advancements in medical technology, clinical guidelines and progress in the pharmaceutical field.

The market size for the prostate specific antigen (PSA) test is predicted to undergo swift expansion in the coming years, rising to a value of $7.29 billion in 2029 with a compound annual growth rate (CAGR) of 11.9%. The growth within this prediction period can be accredited to advancements in the precision of the test, tailored medical approaches, and the increasingly aging global population. Noteworthy trends anticipated within this prediction period encompass a shift to biomarker combinations, technological breakthroughs, point-of-care testing, integration of digital health, and an emphasis on early detection and prevention.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12576

What Are the Major Segments in the Prostate Specific Antigen (PSA) Test Market?
The prostate specific antigen (PSA) test market covered in this report is segmented -

1) By Type: Clinical Laboratory Improvement Amendments (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Fluorescence Immunoassay (FIA), Other Types
2) By Application: Screening, Post-Treatment Monitoring, Other Applications
3) By End User: Hospitals, Diagnostic Centers, Research Institutes, Other End Users

Subsegments:
1) By Clinical Laboratory Improvement Amendments (CLIA): CLIA Waived Tests, Non-CLIA Tests
2) By Enzyme-Linked Immunosorbent Assay (ELISA): Sandwich ELISA Kits, Competitive ELISA Kits
3) By Fluorescence Immunoassay (FIA): Point-Of-Care FIA, Laboratory-Based FIA
4) By Other Types: Chemiluminescent Immunoassay (CLIA), Radioimmunoassay (RIA)

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12576&type=smp

What Are The Driving Prostate Specific Antigen (PSA) Test Market Evolution?
The escalation in the number of prostate cancer cases is anticipated to stimulate the growth of the prostate-specific antigen (PSA) test market. Prostate cancer originates in the prostate gland, a vital part of male and female reproductive systems. The level of PSA in the bloodstream can be detected through a PSA test, making it a popular screening method for diagnosing prostate cancer in men. This test helps in the early detection and risk evaluation of prostate cancer. For instance, a report from the American Society of Clinical Oncology (ASCO), a U.S. based cancer organization, in March 2023, conveyed that an estimated 288,300 men were diagnosed with prostate cancer in the U.S., and around 34,700 individuals lost their lives to the disease in 2023. Hence, the surge in the occurrence of prostate cancer contributes to the expansion of the prostate-specific antigen (PSA) test market.

Which Firms Dominate The Prostate Specific Antigen (PSA) Test Market Segments?
Major companies operating in the prostate specific antigen (PSA) test market include Siemens AG, F. Hoffmann-La Roche AG, Bayer AG, Abbott Laboratories, Becton inson and Company, PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., DiaSorin SpA, OPKO Health Inc., R&D Systems Inc., Meso Scale Diagnostics LLC, Tosoh America Inc., Fujirebio Europe N.V., Boditech Med Inc., DRG International Inc., BioVision Inc., Enzo Life Sciences Inc., RayBiotech Inc., Novus Biologicals LLC, Creative Diagnostics Inc., Elabscience, LifeSpan BioSciences Inc., American Laboratory Products Company Ltd., Accuquik Inc.

What Trends Are Expected to Dominate the Prostate Specific Antigen (PSA) Test Market in the Next 5 Years?
The rise of technology is a prominent trend in the prostate-specific antigen (PSA) test market, as large corporations evolve their screening tools to maintain competitiveness. For instance, LynxDx Inc., an American diagnostics enterprise, introduced MyProstateScore 2.0 in February 2023. This advanced, non-invasive urine screening can detect prostate cancer. The test leverages 18 unique biomarkers, including the groundbreaking gene fusion T2:ERG, to furnish personalized risk evaluations for every patient. Interestingly, this test not only provides precise risk assessments but also aids clinical decision-making in cases with high prostate-specific antigen (PSA) or unusual digital rectal exam (DRE) results. It holds promise for enhancing early detection and treatment of prostate cancer.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/prostate-specific-antigen-psa-test-global-market-report

Which Is The Largest Region In The Prostate Specific Antigen (PSA) Test Market?
North America was the largest region in the prostate specific antigen (PSA) test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate specific antigen (PSA) test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Prostate Specific Antigen (PSA) Test Market?
2. What is the CAGR expected in the Prostate Specific Antigen (PSA) Test Market?
3. What Are the Key Innovations Transforming the Prostate Specific Antigen (PSA) Test Industry?
4. Which Region Is Leading the Prostate Specific Antigen (PSA) Test Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.